Skip to main content
SpringerLink
Log in
Book cover

Carcinoma of the Bladder pp 268–278Cite as

Treatment-Related Complications for Bladder Carcinoma: Radical Surgery Versus Bladder-Preserving Techniques

  • Chapter

  • 164 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

Abstract

The morbidity and mortality of bladder carcinoma treatment are dependent upon which treatment modalities are employed. The treatment should be chosen to best fit the stage of disease. The standard treatment regimen for in situ or early-stage bladder cancer has been transurethral resection of the bladder tumor (TURBT). This treatment is given with or without intravesicular chemotherapy or BCG therapy for many years and is very tolerable with regard to morbidity of normal tissues.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abratt RP, Craighead P, Reddi VB, et al. (1991) A perspective randomized trial of radiation with and without oral and intravesicular misonidazole for bladder cancer. Br J Cancer 64: 968–970

    Article  PubMed  CAS  Google Scholar 

  • Abratt RP, Tuker RD, Barnes DR (1983) Radical irradiation of T2 grade III and T3 bladder cancer, tumor response and prognosis. Int J Radiat Oncol Biol Phys 9: 1213–1215

    Article  PubMed  CAS  Google Scholar 

  • Chauvet B, Brewer W, Felix-Faure C, et al. (1993) Combination radiation therapy and cisplatin for locally advanced carcinoma of the urinary bladder. Cancer 72: 2213–2218

    Article  PubMed  CAS  Google Scholar 

  • Cole DJ, Durrant KR, Roberts JT, et al. (1992) A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. Br J Radiol 65: 792–798

    Article  PubMed  CAS  Google Scholar 

  • Cox JD, Guse C, Asbell S, et al. (1988) Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of protocol 83–08 of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 15: 1331–1336

    Article  PubMed  CAS  Google Scholar 

  • DeNeve W, Lybeert LM, Goor C, et al. (1992) T1 and T2 carcinoma of urinary bladder: long term results with external, preoperative, or interstitial radiotherapy. Int J Radiat Oncol Biol Phys 23: 299–304

    Article  CAS  Google Scholar 

  • Duncan W, Williams JR, Kerr GR, et al. (1986) An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer. Int J Radiat Oncol Biol Phys 12: 2085–2092

    Article  PubMed  CAS  Google Scholar 

  • Dunst J, Sauer R, Schrott KM, et al. (1994) A organ sparing treatment of advanced bladder cancer: a 10 year experience. Int J Radiat Oncol Biol Phys 30: 261–266

    Article  PubMed  CAS  Google Scholar 

  • Freiha FS, Faysal MH (1983) Salvage cystectomy. Urology 23: 496–498

    Article  Google Scholar 

  • Grossman HB, Sandler HM, Perez-Tamayo C (1993) The treatment of T3a bladder cancer with iridium implantation. Urology 41: 217–220

    Article  PubMed  CAS  Google Scholar 

  • Hillcoat BL, Raghaven D, Matthews J, et al. (1989) A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. J Clin Oncol 7: 706–709

    PubMed  CAS  Google Scholar 

  • Horwich A (1991) Treatment of muscle-invasive (T2/T3) disease: the role of radiotherapy. In: Alderson AR, Oliver RTD, Hanham IWF, Bloom HJG (eds) Urological oncology dilemmas and developments. Wiley, Chichester, pp 137–144

    Google Scholar 

  • Housset M, Maulard C, Chretien Y, et al. (1993) Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150–2157

    PubMed  CAS  Google Scholar 

  • Kachnic LA, Shipley WU, Griffin PP, et al. (1996) Combined modality treatment with selective conservative for invasive bladder cancer: long term tolerance in the female patient. Cancer J Sci Am 2: 79–84

    PubMed  CAS  Google Scholar 

  • Khandekar JD, Elson PJ, DeWys WD, et al. (1985) Comparative activity and toxicity of cis-diamminedichloroplatinum and combination of doxorubicin, cyclophosphamide and DDP in disseminated transitional cell carcinomas of the urinary tract. J Clin Oncol 3: 539–545

    PubMed  CAS  Google Scholar 

  • Konnak JW, Grossman HB (1985) Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of the bladder. Urology 26: 550–553

    Article  PubMed  CAS  Google Scholar 

  • Kopelson G, Heaney JA (1983) Postoperative radiation therapy for muscle invading bladder carcinoma. J Surg Oncol 23: 263–268

    Article  PubMed  CAS  Google Scholar 

  • Lamm DL, Steg A, Boccon-Gibod L, et al. (1989) Complications of BCG immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol 310: 335–355

    CAS  Google Scholar 

  • Logothetis CJ, Samuals ML, Ogden S, et al. (1985) Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases. J Urol 134: 460–464

    PubMed  CAS  Google Scholar 

  • Lynch WJ, Jenkins BJ, Fowler CG (1992) The quality of life after radical radiotherapy for bladder cancer. Br J Urol 70: 519–521

    PubMed  CAS  Google Scholar 

  • Mameghan H, Fisher RJ, Watt WH, et al. (1991) Management of invasive transitional cell carcinoma of the bladder. Cancer 69: 2771–2778

    Article  Google Scholar 

  • Marks LB, Kaufman SD, Prout GR Jr, et al. (1988) Invasive bladder carcinoma, preliminary report of selective bladder conservation by transurethral surgery, up front MCV chemotherapy and pelvic irradiation plus cisplatin. Int J Radiat Oncol Biol Phys 15: 877–882

    Article  PubMed  CAS  Google Scholar 

  • Marks LB, Carroll TR, Dugan TC, et al. (1995) Response of urinary bladder, urethra and ureter to irradiation and chemotherapy. Int J Radiat Oncol Biol Phys 31: 1257–1280

    Article  PubMed  CAS  Google Scholar 

  • Mohiuddin M, Kramer S, Newall J, et al. (1985) Combined preoperative and postoperative radiation for bladder cancer. Cancer 55: 963–966

    Article  PubMed  CAS  Google Scholar 

  • Pisters LL, Tykochinsky G, Wajsman Z (1991) Intravesical BCG or mitomycin in the treatment of carcinoma in-situ of the bladder following prior pelvic radiation therapy. J Urol 146: 514–517

    Google Scholar 

  • Raghavan D, Grundy R, Greenaway T, et al. (1988) Preemptive chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contraindication. Br J Urol 62: 154–159

    Article  PubMed  CAS  Google Scholar 

  • Reisinger SA, Mohiuddin M, Mulholland SG (1992) Combined pre- and postoperative adjuvant radiation therapy for bladder cancer; a ten year experience. Int J Radiat Oncol Biol Phys 24: 463–468

    Article  PubMed  CAS  Google Scholar 

  • Roberts JT, Fossa SP, Richards SB, et al. (1991) Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced transitional cell carcinoma of the bladder. Br J Urol 68: 162–168

    Article  PubMed  CAS  Google Scholar 

  • Rotman M, Aziz M, Porrazzo M, et al. (1990) Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5 FU infusion. Int J Radiat Oncol Biol Phys 18: 1131–1137

    Article  PubMed  CAS  Google Scholar 

  • Russell KJ, Boileau MA, Ireton RC, et al. (1988) Transitional cell carcinoma of the urinary bladder: histologic clearance with combined 5-FU chemotherapy and radiation therapy: preliminary results of bladder preservation study. Radiology 167: 845–848

    PubMed  CAS  Google Scholar 

  • Russell KJ, Laramore GE, Griffin TW, et al. (1989) Neutron radiotherapy for treatment of carcinoma of the urinary bladder. Am J Clin Oncol 12: 301–306

    Article  PubMed  CAS  Google Scholar 

  • Shiels RA, Nissenbaum NN, Mark SR, et al. (1986) Late radiation cystitis after treatment for carcinoma of the bladder. S Afr Med J 70: 727–728

    PubMed  CAS  Google Scholar 

  • Shipley WU, Rose MA, Perrone TL, et al. (1985) Full dose irradiation for patients with invasive bladder carcinoma: clinical and historical prognostic factors of improved survival. J Urol 134: 679

    PubMed  CAS  Google Scholar 

  • Shipley WU, Prout GR, Einstein AB, et al. (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258: 931–935

    Article  PubMed  CAS  Google Scholar 

  • Shipley WU, Zietman AL (1996) Bladder cancer: the combination of chemotherapy and irradiation in the treatment of patients with muscle invading tumors. ASTRO refresher course 203

    Google Scholar 

  • Soloway MS, Ishikawa S, Taylor T, et al. (1989) MVAC or MVC for the treatment of advanced transitional cell carcinoma: metastasis, induction and adjuvant. J Surg Oncol 1: 40–45

    Article  CAS  Google Scholar 

  • Soloway MS, Lopez AE, Patel J, et al. (1993) Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 73: 1926–1931

    Article  Google Scholar 

  • Spera JA, Whittington R, Littman P, et al. (1987) A comparison of preoperative radiotherapy regimens for bladder carcinoma. Cancer 61: 255–262

    Article  Google Scholar 

  • Straus KL, Littman P, Wein AJ, et al. (1988) Treatment of bladder cancer with interstitial iridium 192 implantation and external beam irradiation. Int J Radiat Oncol Biol Phys 14: 265–271

    Article  PubMed  CAS  Google Scholar 

  • Studer UE, Gerber E, Zimmermann A, et al. (1993) Late results in patients treated with pi-mesons for bladder cancer. Cancer 71: 439–447

    Article  PubMed  CAS  Google Scholar 

  • Tannock I, Gospodarowicz M, Connolly J, et al. (1989) MVAC chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience. J Urol 142: 289–292

    PubMed  CAS  Google Scholar 

  • Tester W, Porter A, Asbell S, et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85–12. Int J radiat Oncol Biol Phys 25: 783–790

    Article  PubMed  CAS  Google Scholar 

  • Zietman AL, Shipley WU, Kaufman DS (1993) The combination of cisplatin based chemotherapy and radiation in the treatment of muscle invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 27: 161–170

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Cancer Center at Kent General Hospital, Delaware, USA

    B. J. Costleigh MD

  2. Department of Radiation Oncology and Nuclear Medicine, Allegheny University Hospitals, Center City, Mail Stop 200, Broad & Vine Sts., Philadelphia, PA, 19102-1192, USA

    B. J. Costleigh MD, W. A. Longton MD, L. W. Brady MD (Professor), C. T. Miyamoto MD, J. E. Friere MD, B. Micaily MD & F. Farzin MD

Authors
  1. B. J. Costleigh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. A. Longton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. W. Brady MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. T. Miyamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. E. Friere MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Micaily MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Farzin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of Southern California, USC/Norris Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA

    Zbigniew Petrovich MD, FACR (Professor and Chairman) (Professor and Chairman)

  2. Department of Urology, UZ Gasthuisberg, University of Leuven, Herestraat 49, B-3000, Leuven, Belgium

    Luc Baert MD, PhD (Professor and Chairman) (Professor and Chairman)

  3. Department of Radiation Oncology and Nuclear Medicine, Allegheny University Hospitals, Center City, Mail Stop 200, Broad & Vine Sts., Philadelphia, PA, 19102-1192, USA

    Luther W. Brady MD (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Costleigh, B.J. et al. (1998). Treatment-Related Complications for Bladder Carcinoma: Radical Surgery Versus Bladder-Preserving Techniques. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Bladder. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60258-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60258-0_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64323-1

  • Online ISBN: 978-3-642-60258-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation